Mariam K. Alamoudi

Al Kharj, 11942, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Retraction notice to "The experimental significance of isorhamnetin as an effective therapeutic option for cancer: A comprehensive analysis" [Biomedicine & Pharmacotherapy 176 (2024) 116860].

Retraction notice to "The experimental significance of isorhamnetin as an effective therapeutic option for cancer: A comprehensive analysis" [Biomedicine & Pharmacotherapy 176 (2024) 116860].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 05, 2026

Methylglyoxal-derived glycated albumin enhances the stemness potential of invasive ductal carcinoma-derived breast cancer stem-like cell line KAIMRC1.

Methylglyoxal-derived glycated albumin enhances the stemness potential of invasive ductal carcinoma-derived breast cancer stem-like cell line KAIMRC1.

Journal: Oncology letters
Published: October 03, 2025

Synthesis, antiproliferative evaluation and in silico studies of new quinazoline derivatives as VEGFR-2 inhibitors.

Synthesis, antiproliferative evaluation and in silico studies of new quinazoline derivatives as VEGFR-2 inhibitors.

Journal: Future medicinal chemistry
Published: July 04, 2025

Epigenetic regulation of stress.

Epigenetic regulation of stress.

Journal: Progress in brain research
Published: April 13, 2025

Elevated HDAC4 Expression Is Associated with Reduced T-Cell Inflamed Tumor Microenvironment Gene Signatures and Immune Checkpoint Inhibitor Effectiveness in Melanoma.

Elevated HDAC4 Expression Is Associated with Reduced T-Cell Inflamed Tumor Microenvironment Gene Signatures and Immune Checkpoint Inhibitor Effectiveness in Melanoma.

Journal: Cancers
Published: March 26, 2025

Novel triazoloquinazoline derivatives as VEGFR inhibitors: synthesis, cytotoxic evaluation and in silico studies.

Novel triazoloquinazoline derivatives as VEGFR inhibitors: synthesis, cytotoxic evaluation and in silico studies.

Journal: Future medicinal chemistry
Published: February 25, 2025

Targeting p70S6K1 Inhibits Glycated Albumin-Induced Triple-Negative Breast Cancer Cell Invasion and Overexpression of Galectin-3, a Potential Prognostic Marker in Diabetic Patients with Invasive Breast Cancer.

Targeting p70S6K1 Inhibits Glycated Albumin-Induced Triple-Negative Breast Cancer Cell Invasion and Overexpression of Galectin-3, a Potential Prognostic Marker in Diabetic Patients with Invasive Breast Cancer.

Journal: Biomedicines
Published: January 29, 2025

Serum Circ-DLGAP4 and miR-9 as Potential Biomarkers in Pancreatic Cancer.

Serum Circ-DLGAP4 and miR-9 as Potential Biomarkers in Pancreatic Cancer.

Journal: Journal of clinical laboratory analysis
Published: January 24, 2025

An Insight into Pharmaceutical Design and Pharmacokinetic Characteristics of GLP-1 RAs.

An Insight into Pharmaceutical Design and Pharmacokinetic Characteristics of GLP-1 RAs.

Journal: Current pharmaceutical design
Published: December 19, 2024

An Insight into Pharmaceutical Design and Pharmacokinetic Characteristics of GLP-1 RAs.

An Insight into Pharmaceutical Design and Pharmacokinetic Characteristics of GLP-1 RAs.

Journal: Current pharmaceutical design
Published: December 19, 2024

Enhanced inflammatory and oxidative response mitigation by acetyl-L-carnitine in a rat model of pelvic inflammatory disease.

Enhanced inflammatory and oxidative response mitigation by acetyl-L-carnitine in a rat model of pelvic inflammatory disease.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 10, 2024

Ghrelin's modulation of growth hormone secretagogue receptors in primary glioblastoma and meningioma: A comprehensive in-vitro study.

Ghrelin's modulation of growth hormone secretagogue receptors in primary glioblastoma and meningioma: A comprehensive in-vitro study.

Journal: Biochemical and biophysical research communications
Published: November 12, 2024
Showing 1-12 of 25

Last Updated: 09/26/2026